The American Journal of Hematology provides broad coverage of experimental and clinical features of blood diseases in humans and in animal models of human disease. The journal publishes original contributions in non-malignant and malignant hematological diseases including clinical and basic studies in hemostasis and thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports describing novel therapeutic approaches to diagnosis and treatment of hematological diseases are welcomed and encouraged. The journal includes regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, letters and correspondence.
Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord blood transplantation (CBT), which accounts for more than one-third of allo-HSCTs in Japan, ...
Jan 24, 2024
0
0
In a study, published in American Journal of Hematology, Mayo Clinic researchers examined telomere biology disorders, a group of rare genetic disorders characterized by short telomeres.
Oct 12, 2023
0
25
Adverse pregnancy outcomes occur frequently in women with sickle cell disease (SCD) across the globe. Black women in the United States experience disproportionately worse maternal health outcomes than all other racial groups, ...
Jun 28, 2023
0
20
A new paper from researchers at King's, in collaboration with Muhimbili University in Dar es Salaam, provides an in-depth analysis at why people of the female sex may have milder symptoms for sickle cell disease, specifically ...
May 18, 2023
0
2
Clinical characteristics, outcomes, and genetic features vary among different myelodysplastic syndrome (MDS) subtypes categorized using the 2022 International Consensus Classification (ICC), according to a study published ...
Jan 19, 2023
0
28
AL amyloidosis is a life-threatening disease related to bone marrow cancer and multiple myeloma. It is caused when a person's antibody-producing white blood cells (i.e. plasma cells) do not function properly and generate ...
Jul 14, 2022
0
3
Determining an individual's blood group based on genetic tests instead of merely traditional blood tests can provide a better picture of the risk of cardiovascular diseases. If a patient has two genetic variants of A, B or ...
Aug 30, 2021
0
19
Researchers at Karolinska Institutet have investigated the use of low dose venetoclax, an experimental drug, for the treatment of the heterogeneous cancer disease multiple myeloma in patients who had relapsed on standard ...
May 19, 2021
0
27
Patients hospitalized with severe COVID-19 infections who have high levels of the blood clotting protein factor V are at elevated risk for serious injury from blood clots such as deep vein thrombosis or pulmonary embolism, ...
Sep 8, 2020
0
59
(HealthDay)—Blast count seems to be the main prognostic count for patients with chronic myeloid leukemia (CML) presenting in an advanced phase, according to a study published online Aug. 27 in the American Journal of Hematology.
Sep 26, 2019
0
0
